Open AccessOutcomes of Integrase Inhibitor–based Antiretroviral Therapy in a Clinical Cohort of Treatment-experienced Children, Adolescents and Young Adults With HIV Infection
Author(s) -
Matthew E. Levy,
Caleb Griffith,
Nicole Ellenberger,
Anne Monroe,
Amanda D. Castel,
Natella Rakhmanina
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002577
Subject(s) - dolutegravir , medicine , viremia , cohort , young adult , pediatrics , human immunodeficiency virus (hiv) , cohort study , antiretroviral therapy , viral load , immunology
Data on integrase strand transfer inhibitor (INSTI) use in children, adolescents and young adults with HIV are limited. We evaluated virologic and safety outcomes following INSTI initiation among treatment-experienced children, adolescents and young adults.